Current price is more than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Dr Reddy’s Laboratories is also understood to have made to the penultimate round of bidding process, people with direct knowledge of the matter told ET. The transaction will see the exit of existing investors such as ChrysCapital and Sequoia Capital. Promoters are expected to stay on with a minority…

Torrent Pharma, JB Chemicals in final race to acquire Curatio Healthcare

JB Chemicals now plan to enter new areas like sleep disorders, sexual wellness, motion sickness, and immunity apart, from the conventional areas like cough, sore throat, etc.

KKR-backed JB Chemicals bets big on lozenges and probiotic products

JB Chemicals Q3 Review - Continuously Outpacing Domestic Growth: ICICI Securities

JB Chemicals Consolidated December 2021 Net Sales at Rs 600.66 crore, up 9.57% Y-o-Y

JB Chemicals - Foray Into Nutraceuticals, Probiotics: ICICI Securities

JB Chemicals and Pharmaceuticals Ltd on Thursday said it will acquire brands for the Indian market from Sanzyme Pvt Ltd, a player in the probiotics and reproductive health segment, for Rs 628 crore. The brands to be acquired include those in the probiotics portfolio and reproductive health segment o…

JB Chemicals to acquire brands from Sanzyme for Rs 628 crore

JB Chemicals - Poised For A Multi-Year Growth Trajectory: Nirmal Bang Initiates Coverage

Recently Molnupiravir, received U.S. FDA, Emergency Use Authorization(EUA) for the Treatment of Mild to Moderate COVID-19.

JB Chemicals and Pharma to launch Molnupiravir under brand name Molunamax in India soon; Stock surges 2%

JB Chemicals - Beat On Q2, All Round Growth: Dolat Capital

The company records revenue growth of 34% yoy to Rs593cr in Q2FY22.

JB Chemicals & Pharma reports Q2 PAT of Rs98cr up by 32% yoy; Stock trades in green

Check out the stocks that will be in focus during trade today based on recent and latest news developments.

Top stocks in focus: Tata Steel, RailTel, Indiabulls Housing Finance, ZEEL, JB Chemicals & Pharma

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets a range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredient (APIs).

J B Chemicals and Pharmaceuticals Ltd

J B Chemicals and Pharmaceuticals Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Torrent Pharma, JB Chemicals in final race to acquire Curatio Healthcare

KKR-backed JB Chemicals bets big on lozenges and probiotic products

JB Chemicals Q3 Review - Continuously Outpacing Domestic Growth: ICICI Securities

JB Chemicals Consolidated December 2021 Net Sales at Rs 600.66 crore, up 9.57% Y-o-Y

JB Chemicals - Foray Into Nutraceuticals, Probiotics: ICICI Securities

JB Chemicals to acquire brands from Sanzyme for Rs 628 crore

JB Chemicals - Poised For A Multi-Year Growth Trajectory: Nirmal Bang Initiates Coverage

J B Chemicals and Pharmaceuticals Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Torrent Pharma, JB Chemicals in final race to acquire Curatio Healthcare

KKR-backed JB Chemicals bets big on lozenges and probiotic products

JB Chemicals Q3 Review - Continuously Outpacing Domestic Growth: ICICI Securities

JB Chemicals Consolidated December 2021 Net Sales at Rs 600.66 crore, up 9.57% Y-o-Y

JB Chemicals - Foray Into Nutraceuticals, Probiotics: ICICI Securities

JB Chemicals to acquire brands from Sanzyme for Rs 628 crore

JB Chemicals - Poised For A Multi-Year Growth Trajectory: Nirmal Bang Initiates Coverage

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock